Citigroup’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $900K | Sell |
200,000
-139,200
| -41% | -$609K | ﹤0.01% | 3183 |
|
|
2025
Q4 | $1.63M | Sell |
339,200
-100,000
| -23% | -$450K | ﹤0.01% | 2792 |
|
|
2025
Q3 | $1.99M | Buy |
439,200
+139,300
| +46% | +$512K | ﹤0.01% | 2684 |
|
|
2025
Q2 | $927K | Buy |
299,900
+100,000
| +50% | +$332K | ﹤0.01% | 3239 |
|
|
2025
Q1 | $698K | Buy |
199,900
+49,900
| +33% | +$166K | ﹤0.01% | 3497 |
|
|
2024
Q4 | $491K | Sell |
150,000
-167,400
| -53% | -$616K | ﹤0.01% | 3842 |
|
|
2024
Q3 | $1.22M | Buy |
317,400
+32,400
| +11% | +$124K | ﹤0.01% | 3103 |
|
|
2024
Q2 | $881K | Buy |
285,000
+50,000
| +21% | +$150K | ﹤0.01% | 2999 |
|
|
2024
Q1 | $606K | Buy |
235,000
+55,600
| +31% | +$144K | ﹤0.01% | 3437 |
|
|
2023
Q4 | $449K | Sell |
179,400
-15,000
| -8% | -$29.4K | ﹤0.01% | 3478 |
|
|
2023
Q3 | $395K | Hold |
194,400
| – | – | ﹤0.01% | 3235 |
|
|
2023
Q2 | $447K | Buy |
194,400
+94,400
| +94% | +$246K | ﹤0.01% | 3450 |
|
|
2023
Q1 | $303K | Buy |
+100,000
| New | +$282K | ﹤0.01% | 3486 |
|
|
2020
Q4 | – | Sell |
-7,000
| Closed | -$22K | – | 7326 |
|
|
2020
Q3 | $22K | Buy |
+7,000
| New | +$21.3K | ﹤0.01% | 6116 |
|
|
2020
Q2 | – | Sell |
-900
| Closed | -$1K | – | 7509 |
|
|
2020
Q1 | $1K | Buy |
+900
| New | +$2.43K | ﹤0.01% | 7479 |
|
|
2019
Q1 | – | Sell |
-6,000
| Closed | -$23K | – | 7628 |
|
|
2018
Q4 | $23K | Buy |
6,000
+4,300
| +253% | +$21.2K | ﹤0.01% | 6803 |
|
|
2018
Q3 | $16K | Buy |
1,700
+200
| +13% | +$1.99K | ﹤0.01% | 7177 |
|
|
2018
Q2 | $11K | Buy |
1,500
+1,400
| +1,400% | +$8.33K | ﹤0.01% | 7138 |
|
|
2018
Q1 | $1K | Sell |
100
-900
| -90% | -$4.77K | ﹤0.01% | 7420 |
|
|
2017
Q4 | $5K | Buy |
+1,000
| New | +$5.86K | ﹤0.01% | 7214 |
|
|
2017
Q2 | – | Sell |
-3,500
| Closed | -$11K | – | 7319 |
|
|
2017
Q1 | $11K | Sell |
3,500
-124,400
| -97% | -$345K | ﹤0.01% | 6515 |
|
|
2016
Q4 | $313K | Buy |
127,900
+31,400
| +33% | +$91.4K | ﹤0.01% | 4882 |
|
|
2016
Q3 | $332K | Buy |
96,500
+18,000
| +23% | +$70.3K | ﹤0.01% | 4263 |
|
|
2016
Q2 | $273K | Buy |
78,500
+23,900
| +44% | +$101K | ﹤0.01% | 4211 |
|
|
2016
Q1 | $225K | Buy |
54,600
+52,300
| +2,274% | +$187K | ﹤0.01% | 4971 |
|
|
2015
Q4 | $10K | Sell |
2,300
-700
| -23% | -$3.84K | ﹤0.01% | 6803 |
|
|
2015
Q3 | $18K | Buy |
3,000
+2,700
| +900% | +$23.9K | ﹤0.01% | 6093 |
|
|
2015
Q2 | $4K | Buy |
+300
| New | +$4.57K | ﹤0.01% | 6834 |
|
Other funds holding ABUS
TSC
WCM
VCM
RCMNY
ACM